<DOC>
	<DOCNO>NCT00207831</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , 5-fluorouracil , work different way stop growth tumor cell , either kill cell stop divide also radiosensibilisant . Radiation therapy use high-energy x-ray kill tumor cell . 5-fluorouracil may make tumor cell sensitive radiation therapy . Oral 5-fluorouracil convenient ambulatory patient . Giving UFT ( Tegafur Uracil ) radiation therapy surgery may shrink tumor remove . PURPOSE : This phase III trial study well give UFT radiation therapy work treat patient undergo surgery operable rectal cancer .</brief_summary>
	<brief_title>Trial Testing Ftorafur ( UFT ) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone Rectal Adenocarcinoma</brief_title>
	<detailed_description>Adenocarcinoma rectum Stage II/stage III rectal cancer ( T4 anal extension eligible ) Drug : UFT Procedure : chemotherapy Procedure : conventional surgery Procedure : neoadjuvant therapy Procedure : radiation therapy Procedure : radiosensitization Procedure : surgery</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive adenocarcinoma rectum , M0 , low side &lt; 10 cm anal verge T3 T4 disease ( T4 exclusive anal extension ) PATIENT CHARACTERISTICS : Performance status ECOG 02 OR Zubrod 02 Life expectancy Not specify Hematopoietic Absolute neutrophil count &gt; 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hepatic Bilirubin &lt; x2 UNL Renal Creatinine &lt; 150 µMol/L Gastrointestinal No history inflammatory bowel disease No history difficulty inability take absorb oral medication Neurologic Not specify Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No malignancy within past 5 year except curatively treat basal cell skin cancer carcinoma situ cervix No history psychiatric condition diminish mental capacity would preclude study compliance give informed consent PRIOR CONCURRENT THERAPY : Chemotherapy No prior chemotherapy Radiotherapy No prior radiotherapy pelvis Other No concurrent investigational drug No concurrent anticancer treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>neoadjuvant therapy</keyword>
	<keyword>UFT</keyword>
	<keyword>radiochemotherapy</keyword>
</DOC>